MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Piperine potentiate the neuroprotective effect of quercetin against MPTP induced neurotoxicity in rats

    S. Singh, P. Kumar (Moga, India)

    Objective: (1) Quercetin is well tolerated bioflavonoid used as supplement for various disorders but problem is its low oral bioavailability and (2) Piperine is combined…
  • 2017 International Congress

    Brainstem reflexes in patients with neuroleptic-induced akathisia

    A. Gunduz, B. Metin, S. Metin, B. Poyraz, M. Özmen, G. Kiziltan, M. E. Kiziltan, D. Karadeniz (Istanbul, Turkey)

    Objective: We aimed to investigate brainstem reflexes in patients with akathisia. Background: Akathisia is characterized by urge, inner restlessness and constant movement of predominantly lower…
  • 2017 International Congress

    Feasibility of utilizing the NIH Toolbox in Parkinson’s disease subjects with deep brain stimulation

    J. Emerson, P. Dhruva, C. McLeod, R. Moses-Kessler, L. Metman, G. Pal (Chicago, IL, USA)

    Objective: To determine the feasibility of utilizing the NIH Toolbox in moderate to advanced disease Parkinson’s disease (PD) subjects with bilateral subthalamic nucleus deep brain…
  • 2017 International Congress

    Predict cognitive decline with non-clinical markers in Parkinson’s disease

    T. Yousaf, G. Pagano, F. NIccolini, M. Politis (London, United Kingdom)

    Objective: In this study, we investigated whether [123I]FP-CIT single photon emission computed tomography (SPECT) imaging measures and CSF marker profiles predict CI in PD patients…
  • 2017 International Congress

    A new psychosocial intervention for people with Parkinsonian dementias: Adherence, barriers and facilitators

    S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi (Manchester, United Kingdom)

    Objective: To investigate participant adherence and engagement to a home-based, companion-guided cognitive stimulation therapy adapted for people with Parkinsonian dementias (CST-PD). Background: Adherence to rehabilitation…
  • 2017 International Congress

    Cognitive function and impulsive-compulsive behaviors in Parkinson’s disease motor subtypes

    S.-C. Yao, P.-N. Wang, K.-K. Liao, D.-E. Shan (Taipei, Taiwan)

    Objective: To investigate the differences in cognitive function between tremor-dominant (TD) and akinetic-rigid (AR) subtypes of Parkinson disease (PD). Background: Higher rates of dementia, autonomic symptoms,…
  • 2017 International Congress

    Higher risk of cognitive impairment in Parkinson’s disease with comorbid diabetes

    P. Schmidt, F. Cubillos, K. Lyons, C. Marras, T. Davis, E. Nelson, M. Okun (Miami, FL, USA)

    Objective: To determine the risk of cognitive impairment in individuals with Parkinson’s disease (PD) and diabetes. Background: Diabetes is associated with risk of cognitive impairment…
  • 2017 International Congress

    Cognitive impairment in early onset and familial Parkinson’s disease.

    M. Tan, J. Bras, J. Hong, C. Brugaletta, T. Samakomva, K. Hoffmann, S. Lubbe, D. Grosset, N. Wood, A. Schapira, J. Hardy, H. Houlden, H. Morris (London, United Kingdom)

    Objective: The Parkinson’s Families Project (PFP) is a large-scale cohort of early onset (symptom onset <45) and familial Parkinson’s disease (PD) patients. One aim of…
  • 2017 International Congress

    Rare variant analysis of the PPMI dataset to uncover the complex genetic architecture of Parkinson’s disease

    d. BOBBILI, P. MAY, R. KRUEGER (Esch-sur-Alzette, Luxembourg)

    Objective: To unravel the genetic factors that play a role in PD we used the whole exome sequencing data available as a part of Parkinson…
  • 2017 International Congress

    A member of the HSP40/DNAJ family is a novel gene for early-onset parkinsonism

    L. Straniero, I. Guella, V. Rimoldi, L. Parkkinen, A. Young, R. Asselta, J. Follett, G. Soldà, E. Saba, V. Sossi, J. Stoessl, K. Nishioka, N. Hattori, A. Rajput, R. Cilia, S. Goldwurm, M. Farrer, G. Pezzoli, A. Rajput, S. Duga (Rozzano-Milano, Italy)

    Objective: We aim to implicate novel genes/mutations using whole-exome sequencing (WES) in selected pedigrees. Background: Mutations have been identified in only 30% of familial parkinsonism.…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley